Evidence map›Paper›PMID 41814439›Full record

ArticleActa neuropathologica communications2026

Carotid arteries in cerebral small vessel disease and dementia.

Erika Kitajima, Ashley Suwanda, Dan Jobson, Louise Allan, Kian Paydar, Gan Han, Kazuo Washida, Masafumi Ihara, Pazhanichamy Kalailingam, Yoshiki Hase and 3 more

Abstract read
In one paragraph

Article in Acta neuropathologica communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Erika Kitajima *Neurovascular Research Group, Translational and Clinical Research Institute, Campus for Ageing & Vitality, Newcastle University, NE4 5PL, Newcastle Upon Tyne, UK. k_erika@gm.himeji.
Ashley Suwanda *Neurovascular Research Group, Translational and Clinical Research Institute, Campus for Ageing & Vitality, Newcastle University, NE4 5PL, Newcastle Upon Tyne, UK.
Dan Jobson *Neurovascular Research Group, Translational and Clinical Research Institute, Campus for Ageing & Vitality, Newcastle University, NE4 5PL, Newcastle Upon Tyne, UK.ORCID 0000-0003-1151-4827
Louise AllanUniversity of Exeter Medical School, Exeter, UK.ORCID 0000-0002-8912-4901
Kian PaydarNeurovascular Research Group, Translational and Clinical Research Institute, Campus for Ageing & Vitality, Newcastle University, NE4 5PL, Newcastle Upon Tyne, UK.
Gan HanNeurovascular Research Group, Translational and Clinical Research Institute, Campus for Ageing & Vitality, Newcastle University, NE4 5PL, Newcastle Upon Tyne, UK.
Kazuo WashidaDepartment of Neurology, National Cerebral and Cardiovascular Centre, Osaka, Japan.
Masafumi IharaDepartment of Neurology, National Cerebral and Cardiovascular Centre, Osaka, Japan.ORCID 0000-0002-7102-4048
Pazhanichamy KalailingamCenter for Genomic Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA, 02114, USA.ORCID 0000-0002-7689-275X
Yoshiki HaseNeurovascular Research Group, Translational and Clinical Research Institute, Campus for Ageing & Vitality, Newcastle University, NE4 5PL, Newcastle Upon Tyne, UK.ORCID 0000-0002-9538-905X
Siu Kwan SzeFaculty of Applied Health Sciences, Brock University, St. Catharines, ON, L2S 3A1, Canada.ORCID 0000-0002-5652-1687
Tuomo PolvikoskiNeurovascular Research Group, Translational and Clinical Research Institute, Campus for Ageing & Vitality, Newcastle University, NE4 5PL, Newcastle Upon Tyne, UK.
Raj N Kalaria *Neurovascular Research Group, Translational and Clinical Research Institute, Campus for Ageing & Vitality, Newcastle University, NE4 5PL, Newcastle Upon Tyne, UK. raj.kalaria@newcastle.ac.uk.ORCID 0000-0001-7907-4923

Funding

Medical Research Council G0500247Medical Research Council UK G0500247UK Medical Research Council (MRC) G0400074
6 · The paper itself

Abstract

Carotid artery disease (CAD) is a recognised cause of stroke. However, the relationships between CAD, cerebral small vessel disease (SVD) and dementia remain unclear. We hypothesised that CAD in older individuals contributes to cerebral SVD pathology by altering cerebral perfusion. We performed a clinicopathological study in patients from the Cognitive Function After Stroke (CogFAST) study and prospectively recruited patients with various dementia diagnoses and evidence of cerebral SVD. In addition to brain tissues, we collected postmortem samples of the internal carotid arteries (ICA) from these cohorts in the Newcastle Brain Tissue Resource. Standard neuropathological examination was performed for diagnosis and assignment of the cases per current diagnostic criteria for vascular and neurodegenerative dementias, which were assessed for the presence of vascular pathology including the degree of stenosis and sclerosis in vascular tissues. We evaluated a total of 159 ICA samples and brain tissues from all cases with evidence of SVD. Severity of ICA stenosis and sclerotic index correlated strongly with both clinical stroke and brain infarction (P < 0.001). More than 90% of the subjects had one subtype of ICA lesion in the order: intimal thickening > fibrocalcific > fibrous cap (thick) > fibrous cap (thin) > thrombus group with a strong inflammatory reaction in fibrocalcific atheromas. Regression analyses showed that ICA stenosis was positively correlated to both SVD pathology scores (P < 0.034) and the total number of vascular lesions (P < 0.001). ICA stenosis was also related to dementia caused by cerebrovascular disease (P < 0.001) and by mixed pathologies characterised by Alzheimer's disease and SVD (P = 0.025). Severity of stenosis was related to subcortical and white matter (WM) vascular lesions within the anterior circulation. ICA stenosis and sclerosis were moreover correlated with the total intracranial artery pathology scores (P < 0.001). In the CogFAST group analysis, we observed that MMSE and CAMCOG scores were lower in subjects with moderate to severe stenosis scores compared to the mild stenosis group (P < 0.05). In these CogFAST cases, by far the majority of lesions in the WM were small in size (< 5 mm, range 72-91%) but not in the cortex or basal ganglia and thalamus. Linear regression analysis further indicated that there were greater numbers of these small lesions in the WM with increasing severity of ICA stenosis (P < 0.05). Our observations suggest carotid atherosclerosis promotes cerebral SVD types of change within the intracerebral arteries. It is conceivable that extracranial ICA pathology may influence perfusion and integrity of subcortical structures including the deep WM.

Indexed as

BrainCarotid Artery, InternalCerebral Small Vessel DiseasesDementiaAgedAged, 80 and overCarotid StenosisFemaleHumansMaleMiddle AgedAtherosclerosisCarotid artery diseaseSmall vessel diseaseVascular dementiaWhite matter

Identifiers

PMID41814439
PMCPMC13088681

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.